Aaron Mendelsohn, Director at SECOND SIGHT MEDICAL PRODUCTS INC (EYES), bought 30,000 shares at $9.00 ($270K) on 2014-11-19, disclosed to the SEC on 2014-11-21.
Open-market purchase of $270k EYES by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |